Safety Tolerability and Pharmacokinetics of ALD403
Clinical trial NCT01579383 · COMPLETED
Trial details
- NCT number
- NCT01579383
- Sponsor
- Alder Biopharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2012-12-01
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.